Echothiophate

  • Part D specialty tier in 53% of formularies (2026Q3)
  • Phospholine Iodide

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Echothiophate: storage and handling

Refrigerate
Yes, as the label states
Label statement
HANDLING AND STORAGE: Prior to reconstitution: Store under refrigeration (2°C to 8°C).
Freezing
Not addressed
Room temperature
at or below 25°C (77°F)
Label statement
After reconstitution: Store upright at room temperature (approximately 25°C) (68°F to 77° F).
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 25°C (77°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

After reconstitution: Store upright at room temperature (approximately 25°C) (68°F to 77° F).
Discard any unused solution after 4 weeks.

If anything else happened to the product, or you are unsure, Contact the manufacturer about this product; the label text ClinDose has does not print a phone number for it.

All storage statements on the label (4)
  • HANDLING AND STORAGE: Prior to reconstitution: Store under refrigeration (2°C to 8°C).
  • After reconstitution: Store upright at room temperature (approximately 25°C) (68°F to 77° F).
  • Do not refrigerate.
  • Discard any unused solution after 4 weeks.

FDA label version 5, effective July 7, 2025. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

15%of plans list it
0%of those: prior authorization
0%step therapy
0%quantity limit
82%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.